BioCentury
ARTICLE | Financial News

Antibe Therapeutics financial update

August 19, 2013 7:00 AM UTC

Antibe raised C$602,800 ($586,210.94) through the sale of 1.1 million shares at C$0.55 in the second tranche of an IPO, bringing the total raised in the offering to C$2.7 million ($2.7 million). The c...